Cite
APA Citation
Bruera, G., Massacese, S., Pepe, F., Malapelle, U., Dal Mas, A., Ciacco, E., Calvisi, G., Marchetti, P., Troncone, G., Simmaco, M., & Ricevuto, E. (n.d.). p-206Intensive first line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: Preliminary phase II data and individual limiting toxicity syndromes prediction by pharmacogenomic biomarkers. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095522013.0x00002f